483 Response Neopharm Labs Feb 2000

Raymond Oji FDA, Eric Weilage FDA$119.00 - Available Now

FDA investigators audited the Neopharm Labs - Blainville, Canada facility and issued inspectional observation (via FDA 483) on 01 Feb 2000.

Product details

  • Category:
  • Inspection end: 01 Feb 2000
  • Location: Blainville, Canada
  • FEI: 3002807703
Add To Cart